Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm

By Colorcon Inc., PRNE
Wednesday, April 21, 2010

HARLEYSVILLE, Pennsylvania, April 22, 2010 - Colorcon, Inc. today announced the acquisition of the full-service
pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This
acquisition expands Colorcon's global excipient product offerings in the
pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS(R) sugar spheres complements Colorcon's
SureSpheres(R) sugar spheres product line and barrier membrane systems for
multiparticulates. Colorcon will now have two production facilities for sugar
spheres offering critical business continuity planning for their customer
base. ETHISPHERES(R) microcrystalline cellulose pellets, NPTAB(R) neutral
pellets for direct compression, and other excipient products are also added
to the Colorcon product portfolio as a result of this acquisition.

The headquarters and main production facilities of NP Pharm, located in
Bazainville, France, will become an integral part of the Colorcon network of
manufacturing sites.

William Motzer, Colorcon Chief Executive Officer states, "We are excited
about this opportunity to expand Colorcon's product offerings and leverage
our global distribution, technical service and sales infrastructure."

Newly appointed Chairman and CEO of the Management Board of Ethypharm,
Hugues Lecat states, "We are delighted to see NP Pharm join Colorcon, Inc.
The new shareholder will permit NP Pharm to reinforce its development and
growth projects. This divestiture will enable us to go on investing in the
growth of Ethypharm, in line with our strategy. Ethypharm will continue to
invest in its R&D sites, notably that of Grand Quevilly, France, our most
recent state-of-the-art manufacturing plant, in which we have invested over
15 million Euros over the last two years."

About Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical
support of formulated film coating systems, modified release technologies,
and functional excipients for the pharmaceutical industry. Our best-in-class
products and technologies are complemented by our value-added services, which
support all phases of solid oral dose design and development.

About Ethypharm

Ethypharm is one of the leading pharmaceutical companies dedicated to the
development of innovative medicines. Its patented technologies offer multiple
benefits for patients by improving efficacy, administration, compliance, and
reducing side-effects. Ethypharm provides its clients with solutions for the
life cycle management of their drugs. The company has one of the broadest
portfolios of technologies to become the worldwide privileged partner of
pharmaceutical companies. Ethypharm offers customized solutions for the
development of the medicines of the future.

Diane Reitter, Global Communication Director, +1-215-661-2639, dreitter at

will not be displayed